Kunming Longjin Pharmaceutical News

Kunming Longjin Pharmaceutical: Notice of Response to the 2023 Annual Report Inquiry Letter

May 28 00:00

Kunming Longjin Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions

May 22 00:00

Kunming Longjin Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 22 00:00

Kunming Longjin Pharmaceutical: Summary report of the Board Audit Committee on the evaluation of the accounting firm's performance in 2023

May 6 00:00

Kunming Longjin Pharmaceutical: Special instructions on the proposed non-distribution of profits in 2023

Apr 30 00:00

Kunming Longjin Pharmaceutical: 2023 Financial Results Report

Apr 30 00:00

Kunming Longjin Pharmaceutical: Announcement on delisting risk warning and suspension of trading of the company's stock trading

Apr 30 00:00

Kunming Longjin Pharmaceutical: Internal Control Self-Assessment Report

Apr 30 00:00

Kunming Longjin Pharmaceutical: Notice of Annual General Meeting of Shareholders

Apr 30 00:00

Kunming Longjin Pharmaceutical: Notice on Accruing Asset Impairment Preparation and Credit Impairment Preparation

Apr 30 00:00

Longjin Pharmaceutical: An indicative announcement on the risk of delisting risk of the company's stock transactions

Apr 23 00:00

Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management

Apr 20 00:00

Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management

Apr 9 00:00

Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management

Mar 1 00:00

Longjin Pharmaceutical: An indicative announcement on the risk of delisting risk of the company's stock transactions

Mar 1 00:00

Longjin Pharmaceutical: An indicative announcement on the risk of delisting risk of the company\'s stock transactions

Jan 30 00:00

Longjin Pharmaceutical: Announcement on Accrued Asset Impairment Preparation and Credit Impairment Preparation

Jan 30 00:00

Longjin Pharmaceutical: Progress Announcement on the Use of Idle Own Funds for Cash Management

Jan 24 00:00

Longjin Pharmaceutical: Progress Announcement on Using Idle Own Funds for Cash Management

Jan 10 00:00

Longjin Pharmaceutical: Legal Opinion of the 2024 First Extraordinary General Meeting of Shareholders

Jan 4 00:00